Literature DB >> 1613143

Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study.

K Kameyama1, M Morita, K Sugaya, S Nishiyama, V J Hearing.   

Abstract

No successful therapy has been reported for reticulate acropigmentation of Kitamura, which is an autosomal dominant dermatosis. We treated a patient with 20% azelaic acid ointment. Within several weeks the pigmentation was remarkably decreased and no side effects were observed. Histologic examination revealed an increased number of dopa-positive melanocytes. These cells reacted strongly to staining with antityrosinase antibody or antityrosinase-related protein antibody. Electron microscopic findings showed many melanosomes within melanocytes, keratinocytes, and melanophages. These findings suggest that the hyperpigmentation of reticulate acropigmentation of Kitamura is the result of an excess amount of melanin production caused by activation of melanocytes in the basal layer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1613143     DOI: 10.1016/0190-9622(92)70112-s

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Reticulate acropigmentation of Kitamura: A familial case with eyelid involvement.

Authors:  Preema Sinha; Anamika Sinha; Sukriti Baveja; Manas Chatterjee
Journal:  Med J Armed Forces India       Date:  2014-08-14

2.  Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.

Authors:  Jennifer C Tang; Julia Escandon; Michael Shiman; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2012-05

3.  Acropigmentation of Kitamura with immigration delay disease: A rare entity.

Authors:  Sumir Kumar; Bharat Bhushan Mahajan; Nidhi Kamra; Pritish A Bhoyar
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

Review 4.  Clinical and Genetic Review of Hereditary Acral Reticulate Pigmentary Disorders.

Authors:  H Alshaikh; F Alsaif; S Aldukhi
Journal:  Dermatol Res Pract       Date:  2017-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.